The COX-2 inhibitor was OK’d for the treatment of acute migraine in adults with or without aura more than 20 years after the drug's initial approval for pain indications.
from Front page feed https://ift.tt/3dwsnQC
from Front page feed https://ift.tt/3dwsnQC
Comments
Post a Comment